StockWatch
·

Shukra Pharmaceuticals Ltd Q4 FY25 Results

SHUKRAPHARQ4 FY25 Results
Filing
MetricValue (₹ Cr)vs Q3 FY25
Revenue13.2725.4%
Total Income14.7427.1%
Expenditure7.164.4%
PBT7.5784.9%
Net Profit5.3970.3%
OPM55.16%34.00pp
NPM36.56%9.26pp
EPS0.1283.3%
View full financials

Informational and educational content only. Not investment advice.